New opportunities in life science developments and lab space explored

Last week the Macquarie Park Innovation District ecosystem and stakeholders came together to discuss new opportunities in life science developments and lab enabled spaces.

It's clear that the district has a unique value proposition to grow its life science capability further from recent developments including the $96M new RNA Pilot & Research Manufacturing Facility supported by Office of the NSW Chief Scientist & Engineer, Wentworth's $200M investment into lab assets at North Ryde, ARC Centre of Excellence in Synthetic Biology and Macquarie University's Deeptech Incubator.

At the event guests heard lessons from international precincts from Knight Frank Australia's Sam Biggins and received an overview of lab enabled fit out best practices from Unispace Sam Gill.

The industry panel moderated by Stockland's Niki Douglas featured Andrew Hoyne Paul Young and Ashlie Hartigan discussing practical needs for life science precincts:

🚶‍♀️ Greater active transport improvements to connect up developments
🍽 More amenity and activation such a food & beverage
🔬 Scaleup labs and space after startups graduate from University labs
👨‍🔬 Deep specialisation focus of each sub-precinct and developments
🤝 Curated innovation centres of clustering and activation

Thanks to Woolcock Institute of Medical Research Greg Kaplan for hosting, and to all the speakers and attendees who added to the discussion.

Keep an eye for a new Connect Macquarie Park Innovation District industry prospectus for the district which will articulate its value proposition for industry.